NANOLEK
About us
  • Team
  • History
  • Strategy, mission, values
  • Honors and awards
  • Education and CSR
  • Occupational Safety and Health
  • Partners
R&D
Products
  • Vaccines
  • Biotechnology products
  • Chemical products
  • Contract manufacture
  • Other products
Manufacturing
  • Biopharmaceuticals
  • Solid dosage forms
  • Quality control
  • Certificates
Press center
  • Company news
    • Company news
    • Photo gallery
    • Media kit
    • Media contacts
  • Photo gallery
  • Media kit
  • Media contacts
Careers
  • Vacancies
    • Vacancies
    • Corporate culture
  • Corporate culture
Contacts
Ещё
    Ask a question
    info@nanolek.ru
    Moscow, Butyrsky Val, 68, bldg. 1 Baker Plaza Business Center, 2nd floor, office 24
    • Vkontakte
    • Facebook
    • Instagram
    • YouTube
    EN | RU
    NANOLEK
    About us
    • Team
    • History
    • Strategy, mission, values
    • Honors and awards
    • Education and CSR
    • Occupational Safety and Health
    • Partners
    R&D
    Products
    • Vaccines
    • Biotechnology products
    • Chemical products
    • Contract manufacture
    • Other products
    Manufacturing
    • Biopharmaceuticals
    • Solid dosage forms
    • Quality control
    • Certificates
    Press center
    • Company news
    • Photo gallery
    • Media kit
    • Media contacts
    Careers
    • Vacancies
    • Corporate culture
    Contacts
      NANOLEK
      About us
      • Team
      • History
      • Strategy, mission, values
      • Honors and awards
      • Education and CSR
      • Occupational Safety and Health
      • Partners
      R&D
      Products
      • Vaccines
      • Biotechnology products
      • Chemical products
      • Contract manufacture
      • Other products
      Manufacturing
      • Biopharmaceuticals
      • Solid dosage forms
      • Quality control
      • Certificates
      Press center
      • Company news
      • Photo gallery
      • Media kit
      • Media contacts
      Careers
      • Vacancies
      • Corporate culture
      Contacts
        NANOLEK
        EN | RU
        NANOLEK
        • About us
          • Back
          • About us
          • Team
          • History
          • Strategy, mission, values
          • Honors and awards
          • Education and CSR
          • Occupational Safety and Health
          • Partners
        • R&D
        • Products
          • Back
          • Products
          • Vaccines
          • Biotechnology products
          • Chemical products
          • Contract manufacture
          • Other products
        • Manufacturing
          • Back
          • Manufacturing
          • Biopharmaceuticals
          • Solid dosage forms
          • Quality control
          • Certificates
        • Press center
          • Back
          • Press center
          • Company news
            • Back
            • Company news
            • Company news
            • Photo gallery
            • Media kit
            • Media contacts
          • Photo gallery
          • Media kit
          • Media contacts
        • Careers
          • Back
          • Careers
          • Vacancies
            • Back
            • Vacancies
            • Vacancies
            • Corporate culture
          • Corporate culture
        • Contacts
        info@nanolek.ru
        Moscow, Butyrsky Val, 68, bldg. 1 Baker Plaza Business Center, 2nd floor, office 24
        • Vkontakte
        • Facebook
        • Instagram
        • YouTube

        • NANOLEK

          We protect the lives and health of people, making the world's best technologies available to everyone

          About us Products
        • Prev
        • Next
        Innovation
        Innovative Russian vaccines to ensure the biological protection of the population
        Quality
        Quality medicines at affordable prices
        Technology
        High-tech production in accordance with international standards
        Significance
        Focus on prevention and treatment of socially significant diseases

        Press center

        Subscribe
        • BeiGene and Nanolek Announce Approval in Russia for BRUKINSA® (Zanubrutinib) for Treatment of Patients with Relapsed or Refractory Mantle Cell Lymphoma
          Company news
          BeiGene and Nanolek Announce Approval in Russia for BRUKINSA® (Zanubrutinib) for Treatment of Patients with Relapsed or Refractory Mantle Cell Lymphoma
          21.10.2021
        • Maxim Stetsyuk Takes Part in the Forbes Conference "Sustainable Healthcare, Investments, Technologies, and Management"
          Company news
          Maxim Stetsyuk Takes Part in the Forbes Conference "Sustainable Healthcare, Investments, Technologies, and Management"
          08.10.2021
        • Maxim Stetsyuk Takes Part in the Import Substitution Session of the Biotechmed Forum
          Company news
          Maxim Stetsyuk Takes Part in the Import Substitution Session of the Biotechmed Forum
          06.10.2021
        • Sanofi Pasteur and Nanolek Sign an Agreement on Domestic Production of Meningitis Vaccines to Produce up to 3.5 Million Doses Annually in Russia Starting From 2022
          Company news
          Sanofi Pasteur and Nanolek Sign an Agreement on Domestic Production of Meningitis Vaccines to Produce up to 3.5 Million Doses Annually in Russia Starting From 2022
          04.10.2021
        • New Vaccines Are Created Here: The Nanolek R&D Centre Opens Up in Pushchino - a Science City Near Moscow
          Company news
          New Vaccines Are Created Here: The Nanolek R&D Centre Opens Up in Pushchino - a Science City Near Moscow
          20.09.2021
        • The Federal Antinomopoly Service (fas) approves the maximum sale price for Covidolek
          Company news
          The Federal Antinomopoly Service (fas) approves the maximum sale price for Covidolek
          10.09.2021
        • Nanolek to allocate 10 million rubles for support of a cardiology center in the Kirov region
          Company news
          Nanolek to allocate 10 million rubles for support of a cardiology center in the Kirov region
          02.08.2021
        • Maxim Stetsyuk, First Deputy General Director of Nanolek, speaks at the conference on COVID-19 organized by the All-Russian Union of Patients
          Company news
          Maxim Stetsyuk, First Deputy General Director of Nanolek, speaks at the conference on COVID-19 organized by the All-Russian Union of Patients
          02.08.2021
        • Vladimir Khristenko, President of Nanolek, attends the Trust Summit organized by Boston Consulting Group
          Company news
          Vladimir Khristenko, President of Nanolek, attends the Trust Summit organized by Boston Consulting Group
          29.07.2021
        • Developers of medical products for the treatment of sepsis and severe forms of COVID-19 raise 200 million rubles in investment for development purposes
          Company news
          Developers of medical products for the treatment of sepsis and severe forms of COVID-19 raise 200 million rubles in investment for development purposes
          08.07.2021
        • 16,000 locally produced packages of a drug to treat multiple myeloma launched on the Russian market
          Company news
          16,000 locally produced packages of a drug to treat multiple myeloma launched on the Russian market
          02.07.2021
        • Positive results were obtained for the drug Brukinsa (Zanubrutinib) in a comparative trial with Ibrutinib
          Company news
          Positive results were obtained for the drug Brukinsa (Zanubrutinib) in a comparative trial with Ibrutinib
          18.06.2021
        About us
        Team
        History
        Strategy, mission, values
        Honors and awards
        Education and CSR
        Occupational Safety and Health
        Partners
        Press center
        Company news
        Photo gallery
        Media kit
        Media contacts
        Manufacturing
        Biopharmaceuticals
        Solid dosage forms
        Quality control
        Certificates
        Compliance
        Privacy policy
        Pharmacovigilance
        Subscribe
        info@nanolek.ru
        Moscow, Butyrsky Val, 68, bldg. 1 Baker Plaza Business Center, 2nd floor, office 24
        • Vkontakte
        • Facebook
        • Instagram
        • YouTube
        PRIVACY POLICY
        © 2021